This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

NDGA

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What NDGA Means in Everyday Medical Language

NDGA stands for nordihydroguaiaretic acid, a drug often known by other names such as Actinex or masoprocol. It is mainly used as a medication applied directly to the skin to treat growths caused by sun damage. These growths can be harmless or precancerous, meaning they might develop into skin cancer if left untreated. NDGA belongs to a group of substances called antioxidants, which help protect cells from damage caused by harmful molecules called free radicals. It may also block certain enzymes that tumors need to grow.

Why NDGA Can Matter in Cancer Care

Sun damage can cause skin growths that sometimes lead to skin cancer. By treating these growths with NDGA, doctors aim to reduce or control them before they become more serious. Beyond its skin use, researchers are studying an oral (taken by mouth) form of NDGA to see if it can help treat prostate cancer by slowing tumor growth. This research is still ongoing, and oral NDGA is not yet a standard treatment for prostate cancer or other cancers. Its ability to block enzymes related to tumor growth is a key reason for this research interest.

What Patients Might See or Hear About NDGA

You might come across NDGA in your medical records, treatment plans, or when discussing skin care related to sun damage. It may also appear in information about clinical trials if you are exploring new treatments for prostate cancer. Because NDGA has several names—Actinex, masoprocol, and nordihydroguaiaretic acid—you might see these used interchangeably. Knowing these names can help you recognize when your care team or information sources are talking about the same drug.

What NDGA Does Not Automatically Mean

Hearing about NDGA does not mean you have cancer or that this drug is a guaranteed treatment for your condition. Its main approved use is for skin growths caused by sun damage, not all types of cancer. The oral form being studied for prostate cancer is still experimental and not widely available as a standard therapy. NDGA is not a cure-all, and not every patient will be prescribed this medication.

Common Sources of Confusion and Practical Questions

Because NDGA has multiple names, patients sometimes get confused when they see different terms for the same drug. If you are unsure, ask your healthcare provider to clarify which form of the drug is being discussed and how it applies to your care. You might want to ask questions like: What form of NDGA am I receiving—topical or oral? How does this medication work for my condition? Are there side effects I should watch for? Is this treatment part of a clinical trial or standard therapy?

How to Read NDGA in Context

When you see NDGA mentioned, pay attention to whether it refers to a skin treatment or an oral drug under study. Understanding the difference between approved uses and experimental studies can help you make informed decisions. If NDGA comes up during a visit or in medical reports, it may be in the context of skin lesion treatment or clinical trials. Always discuss with your healthcare team what it means for your care personally rather than relying on the term alone.

Safety and Next Steps

This information about NDGA is educational and does not replace advice from your doctors. If you hear about NDGA, consider asking your care team what it means for your treatment options, whether clinical trials are available, and how it might fit into your overall care plan. Staying informed and asking questions can help you feel more confident in your cancer journey.

Sources

Public source information used for this glossary entry includes: